5 completed, 1 withdrawn. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 5, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Fungemia: new trials by email Literature Review of Fungemia trials Research Report on Fungemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers Fluconazole Loading Dose, Fluconazole Loading Dose & High Dose - Candidiasis | Phase 1 | Completed | Daniel Benjamin | 13 | 2008-11-01 | 2018-11-05 |
| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia hLF1-11, Placebo - Candidaemia | Phase 1 / Phase 2 | Withdrawn | AM-Pharma | 2008-07-01 | 2015-06-30 | |
| Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug Micafungin - Oropharyngeal Candidiasis, Candidemia | Phase 1 | Completed | Astellas Pharma Inc | 84 | 2007-10-14 | 2024-11-18 |
| Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug Micafungin (Mycamine) - Invasive Candidiasis, Esophageal Candidiasis | Phase 1 | Completed | Astellas Pharma Inc | 9 | 2007-10-01 | 2014-08-20 |
| Voriconazole to Prevent Systemic Fungal Infections in Children Voriconazole - Aspergillosis, Candidiasis | Phase 1 | Completed | National Cancer Institute (NCI) | 48 | 2000-06-01 | 2008-03-04 |
| Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia FK463 - Fever, Mycoses | Phase 1 | Completed | National Cancer Institute (NCI) | 120 | 1998-10-01 | 2008-03-04 |
Candidiasis (5) · Candidemia (4) · Aspergillosis (2) · Candidiasis, Invasive (2) · Mycoses (2) · Fever (1) · Neutropenia (1) · Sepsis (1) · Torulopsis (1)
Bacterial Infections and Mycoses (6) · Infections (6) · Inflammation (6) · Invasive Fungal Infections (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Systemic Inflammatory Response Syndrome (6) · Sepsis (5) · Mycoses (4) · Candidiasis, Invasive (2) · Agranulocytosis (1) · Body Temperature Changes (1) · Candidiasis (1) · Cytopenia (1)
Micafungin (3) · Fluconazole (1) · Voriconazole (1) · lactoferrin (1-11), human (1)
Astellas Pharma Inc (2) · National Cancer Institute (NCI) (2) · AM-Pharma (1) · Daniel Benjamin (1)
United States (5) · Netherlands (1) · South Africa (1)
Daniel Benjamin, MD (1) · Professor P.E. Verweij, MD, PhD (1)